Why cetuximab may not work while vectibix will:biomarker S492R mutation in EGFR
www.digitaljournal.com/pr/1530586
and an item on another nano approach to CRC
http://phys.org/print301131024.html
while a US-Russian collaboration is developing something called entolimod,CBLB502(some might also want to delve into OncoVax or TAS-102 or U3-1565 or labetuzumab)
Comments
-
Well here I was wondering
Why after tumor testing my onc switched me to Vectibix, now I wonder no more.
Thanks hon,
Winter Marir
0 -
That might not be onc's reason as i had read some timeherdizziness said:Well here I was wondering
Why after tumor testing my onc switched me to Vectibix, now I wonder no more.
Thanks hon,
Winter Marir
ago researchers suggesting switching from one to the other if the first stops working. Also, tho you might be predominantly KRAS wild at start of Tx,KRAS mutatant might become more prominant as therapy continues.As hard as we fight to kill cancer, the cells themselves are fighting to survive...We have to be stronger
(also,overexpression of a gene known as MET (there it is,an inch to the left of your screen)can also ultimately stop cetuximab from being effective; i'm sure there are other causes as well-there seems to be so many variables and every other day someone publishes research on another gene,protein,molecule that may or may not inhibit,nourish or do something else in CRC)
0 -
ActuallycoloCan said:That might not be onc's reason as i had read some time
ago researchers suggesting switching from one to the other if the first stops working. Also, tho you might be predominantly KRAS wild at start of Tx,KRAS mutatant might become more prominant as therapy continues.As hard as we fight to kill cancer, the cells themselves are fighting to survive...We have to be stronger
(also,overexpression of a gene known as MET (there it is,an inch to the left of your screen)can also ultimately stop cetuximab from being effective; i'm sure there are other causes as well-there seems to be so many variables and every other day someone publishes research on another gene,protein,molecule that may or may not inhibit,nourish or do something else in CRC)
I'd been off chemo for 5 months and he had a lot of testing done on this last tumor, the cetuximab was only used for three months and worked very well in conjunction with the Irinotican, when I stopped getting it because of upcoming surgeries, but after looking a tumor test results before starting chemo again after this long lovely break from it, he said he was changing to Vetixmab (or however it's spelled, I forgot again). I'll have to ask my onc why I guess.
Winter Marie
0 -
Vectibix
I haven't been on for a week or so, and if you might have seen one of my last posts back then the cetuximab worked amazing for the 1st 3 mos, but things went crazy the 2nd 3 mos with all kinds of new small lesions and new ones on my pancreas, peritoneum, and omentum fat. My onc has run out of options for me and did the genome testing. There is only one phase 1 study going on over in Dallas that he is trying to get me into. I'll ask him to read up on vectibix to see if that that is a better option for me. Thanks for being diligent and informativee.
Dan
0 -
This article on KRAS hit the internet todayunknown said:Vectibix
I haven't been on for a week or so, and if you might have seen one of my last posts back then the cetuximab worked amazing for the 1st 3 mos, but things went crazy the 2nd 3 mos with all kinds of new small lesions and new ones on my pancreas, peritoneum, and omentum fat. My onc has run out of options for me and did the genome testing. There is only one phase 1 study going on over in Dallas that he is trying to get me into. I'll ask him to read up on vectibix to see if that that is a better option for me. Thanks for being diligent and informativee.
Dan
http://medicalxpress.com/print301487071.html
and i'll repost this one
www.pharmabiz.com/NewsDetails.aspx?aid=77553&sid=2
and add this
www.fortmilltimes.com/2013/10/14/3023636/integragen-obtains-exclusive-license.html
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards